---
$id: https://graph.org.ai/products/commodity/51143013
$type: Product
source: UNSPSC
code: "51143013"
title: "Centrophenoxine or meclofenoxate"
class: "51143000"
classTitle: "Nootropics"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Centrophenoxine or meclofenoxate

**UNSPSC Code**: 51143013
**Class**: [Nootropics](Nootropics.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a neuroprotective agent and nootropic agent with the molecular formula C12H16ClNO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C76QQ2I0RG, chemically known as acetic acid, (p-chlorophenoxy)-, 2-(dimethylamino)ethyl ester, hydrochloride but generally known as meclofenoxate, which bears US NIH Compound Identifier 4039. European Medicines Agency schedules Meclofenoxate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08679MIG. World Health Organization schedules meclofenoxate in its Anatomical Therapeutic Chemical (ATC) Classification. MECLOFENOXATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: CN(C)CCOC(=O)COC1=CC=C(C=C1)CL.

